Maarten van Egmond

18 Chapter 1 al. Landelijke evidence based richtlijn oesophaguscarcinoom [internet]. http://www. oncoline.nl/oesofaguscarcinoom. Updated 2011. Accessed 5/5, 2011. 18. Eyck BM, van der Wilk, B. J., Lagarde SM, et al. Neoadjuvant chemoradiotherapy for resectable oesophageal cancer. Best Pract Res Clin Gastroenterol . 2018;36-37:37-44. 19. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med . 2002;347(21):1662-1669. 20. Biere SS, van Berge Henegouwen, M. I., Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicentre, open- label, randomized controlled trial. Lancet . 2012;379(9829):1887-1892. 21. van der Werf, L. R., Busweiler LAD, van Sandick JW, van Berge Henegouwen, M. I., Wijnhoven BPL, Dutch Upper GI Cancer Audit (DUCA) group. Reporting national outcomes after esophagectomy and gastrectomy according to the esophageal complications consensus group (ECCG). Ann Surg . 2019. 22. van Heijl M, van Lanschot JJ, Blom RL, et al. Outcomes of 16 years of oesophageal surgery: Low postoperative mortality and improved long-term survival]. Ned Tijdschr Geneeskd . 2010;154:A1156. 23. Awad S, Tan BH, Cui H, et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr . 2012;31(1):74-77. 24. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: Revised european consensus on definition and diagnosis. Age Ageing . 2019;48(1):16-31. 25. Miyata H, Sugimura K, Motoori M, et al. Clinical assessment of sarcopenia and changes in body composition during neoadjuvant chemotherapy for esophageal cancer. Anticancer Res . 2017;37(6):3053-3059. 26. Elliott JA, Doyle SL, Murphy CF, et al. Sarcopenia: Prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg . 2017;266(5):822-830. 27. Paireder M, Asari R, Kristo I, et al. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. Eur J Surg Oncol . 2017;43(2):478-484. 28. Makiura D, Ono R, Inoue J, et al. Preoperative sarcopenia is a predictor of postoperative pulmonary complications in esophageal cancer following esophagectomy: A retrospective cohort study. J Geriatr Oncol . 2016;7(6):430-436. 29. World Health Organization. Towards a common language for functioning, disability and health: ICF. In: Geneva, Switserland: World Health Organization; 2002. 30. Jette AM. Toward a common language for function, disability, and health. Phys Ther . 2006;86(5):726-734. 31. Bornbaum CC, Doyle PC, Skarakis-Doyle E, Theurer JA. A critical exploration of the international classification of functioning, disability, and health (ICF) framework from the perspective of oncology: Recommendations for revision. J Multidiscip Healthc . 2013;6:75- 86. 32. van Heijl M, Sprangers MA, de Boer AG, et al. Preoperative and early postoperative quality of life predict survival in potentially curable patients with esophageal cancer. Ann Surg Oncol . 2010;17(1):23-30. 33. Minnella EM, Awasthi R, Loiselle SE, Agnihotram RV, Ferri LE, Carli F. Effect of exercise and nutrition prehabilitation on functional capacity in esophagogastric cancer surgery: A randomized clinical trial. JAMA Surg . 2018. 34. Chen CH, Ho-Chang, Huang YZ, Hung TT. Hand-grip strength is a simple and effective outcome predictor in esophageal cancer following esophagectomy with reconstruction: A prospective study. J Cardiothorac Surg . 2011;6:98-98.